Glaser D A, Remlinger K
Division of Dermatology, Saint Louis University School of Medicine, Missouri, USA.
Cutis. 1996 Apr;57(4):243-4.
Nail dyschromia in patients infected with human immunodeficiency virus (HIV) was first described in 1987 by Furth and Kazakis. It has since been reported in many patients with the acquired immunodeficiency syndrome (AIDS), predominantly in those taking azidothymidine. There have been only three reports of nail pigmentation in HIV-infected patients who had not received azidothymidine. We describe such a case.
1987年，弗思和卡扎基斯首次描述了感染人类免疫缺陷病毒（HIV）患者的指甲色素沉着异常。此后，在许多获得性免疫缺陷综合征（AIDS）患者中都有相关报道，主要是那些服用齐多夫定的患者。在未接受齐多夫定治疗的HIV感染患者中，仅有3例指甲色素沉着的报道。我们在此描述这样一例病例。
